Interim Guidelines on Antiviral Therapy for COVID-19
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sun Bean | - |
dc.contributor.author | Huh, Kyungmin | - |
dc.contributor.author | Heo, Jung Yeon | - |
dc.contributor.author | Joo, Eun-Jeong | - |
dc.contributor.author | Kim, Youn Jeong | - |
dc.contributor.author | Choi, Won Suk | - |
dc.contributor.author | Kim, Yae-Jean | - |
dc.contributor.author | Seo, Yu Bin | - |
dc.contributor.author | Yoon, Young Kyung | - |
dc.contributor.author | Ku, Nam Su | - |
dc.contributor.author | Jeong, Su Jin | - |
dc.contributor.author | Kim, Sung-Han | - |
dc.contributor.author | Peck, Kyong Ran | - |
dc.contributor.author | Yeom, Joon Sup | - |
dc.date.accessioned | 2021-08-30T22:21:58Z | - |
dc.date.available | 2021-08-30T22:21:58Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-06 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/55518 | - |
dc.description.abstract | Since the first case was reported in Wuhan, Hubei Province, China on December 12, 2019, Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January 2020. As of April 16, 2020, 10635 confirmed cases have been reported, with 230 deaths in Korea. COVID-19 patients may be asymptomatic or show various clinical manifestations, including acute symptoms such as fever, fatigue, sore throat; pneumonia presenting as acute respiratory distress syndrome; and multiple organ failure. As COVID-19 has such varied clinical manifestations and case fatality rates, no standard antiviral therapy regimen has been established other than supportive therapy. In the present guideline, we aim to introduce potentially helpful antiviral and other drug therapies based on in vivo and in vitro research and clinical experiences from many countries. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC ANTIMICROBIAL THERAPY | - |
dc.subject | ACUTE-RESPIRATORY-SYNDROME | - |
dc.subject | SYNDROME CORONAVIRUS INFECTION | - |
dc.subject | CRITICALLY-ILL PATIENTS | - |
dc.subject | IN-VITRO INHIBITION | - |
dc.subject | MERS-COV | - |
dc.subject | CONVALESCENT PLASMA | - |
dc.subject | EBOLA-VIRUS | - |
dc.subject | CORTICOSTEROID-THERAPY | - |
dc.subject | LOPINAVIR-RITONAVIR | - |
dc.subject | TRIPLE COMBINATION | - |
dc.title | Interim Guidelines on Antiviral Therapy for COVID-19 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Won Suk | - |
dc.contributor.affiliatedAuthor | Yoon, Young Kyung | - |
dc.identifier.doi | 10.3947/ic.2020.52.2.281 | - |
dc.identifier.scopusid | 2-s2.0-85087948730 | - |
dc.identifier.wosid | 000546188600018 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, v.52, no.2, pp.281 - 304 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 52 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 281 | - |
dc.citation.endPage | 304 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002603568 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | ACUTE-RESPIRATORY-SYNDROME | - |
dc.subject.keywordPlus | SYNDROME CORONAVIRUS INFECTION | - |
dc.subject.keywordPlus | CRITICALLY-ILL PATIENTS | - |
dc.subject.keywordPlus | IN-VITRO INHIBITION | - |
dc.subject.keywordPlus | MERS-COV | - |
dc.subject.keywordPlus | CONVALESCENT PLASMA | - |
dc.subject.keywordPlus | EBOLA-VIRUS | - |
dc.subject.keywordPlus | CORTICOSTEROID-THERAPY | - |
dc.subject.keywordPlus | LOPINAVIR-RITONAVIR | - |
dc.subject.keywordPlus | TRIPLE COMBINATION | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | Antiviral | - |
dc.subject.keywordAuthor | Treatment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.